Cita APA (7a ed.)

YH, P., L, J., CY, L., CH, L., L, L., HY, C., . . . Y, H. (2018). Combined treatment with metformin and gefitinib overcomes primary resistance to EGFR-TKIs with EGFR mutation via targeting IGF-1R signaling pathway. Dove Medical Press.

Cita Chicago Style (17a ed.)

YH, Pan, Jiao L, Lin CY, Lu CH, Li L, Chen HY, Wang YB, y He Y. Combined Treatment with Metformin and Gefitinib Overcomes Primary Resistance to EGFR-TKIs with EGFR Mutation via Targeting IGF-1R Signaling Pathway. Dove Medical Press, 2018.

Cita MLA (8a ed.)

YH, Pan, et al. Combined Treatment with Metformin and Gefitinib Overcomes Primary Resistance to EGFR-TKIs with EGFR Mutation via Targeting IGF-1R Signaling Pathway. Dove Medical Press, 2018.